Wendy G. Lane, MD, MPH and Rebecca R. Seltzer, MD, MHS
If it is ethically justifiable for clinicians to err by overreporting suspected abuse and neglect, we must fairly distribute benefits and harms among all children and families.
AMA J Ethics. 2023;25(2):E133-140. doi:
10.1001/amajethics.2023.133.
Spread of health misinformation by health professionals who also hold government positions represents a long-standing problem exacerbated during the COVID-19 pandemic.
AMA J Ethics. 2023;25(3):E210-218. doi:
10.1001/amajethics.2023.210.
Rebekah Davis Reed, PhD, JD and Erik L. Antonsen, PhD, MD
Though the National Aeronautics and Space Administration’s collection of disaggregated genetic data for occupational surveillance and research raises numerous privacy concerns, the Genetic Information Nondiscrimination Act of 2008 allows genetic information to be used to develop personal pharmaceuticals.
AMA J Ethics. 2018;20(9):E849-856. doi:
10.1001/amajethics.2018.849.
Cynthia E. Schairer, PhD, Caryn Kseniya Rubanovich, MS, and Cinnamon S. Bloss, PhD
Questions about data privacy need to be addressed when research institutions negotiate with companies developing mobile health applications. Commercial terms of use and data sharing notifications should be reviewed before use in human subject research settings.
AMA J Ethics. 2018;20(9):E864-872. doi:
10.1001/amajethics.2018.864.